Regaloside B is primarily studied for its potential anti-inflammatory and immunomodulatory effects. It has shown activity in reducing pro-inflammatory cytokines, making it a candidate for research in inflammatory diseases such as arthritis and certain autoimmune conditions. Additionally, Regaloside B exhibits antioxidant properties, which may contribute to cellular protection against oxidative stress. It is also being explored for its neuroprotective potential, with preliminary studies suggesting it may help in models of neurodegenerative disorders by inhibiting neuroinflammation and supporting neuronal survival. Due to its natural origin and bioactive profile, it serves as a lead compound in the development of herbal-based therapeutics and nutraceuticals targeting chronic inflammation and age-related diseases.